Search Results - "HESS, A. D"

Refine Results
  1. 1

    Learning and implementation of TransREctus sheath PrePeritoneal procedure for inguinal hernia repair by Zwols, T. L. R., van der Bilt, A. R. M., Veeger, N. J. G. M., Möllers, M. J. W., Hess, D. A., Brandsma, H. T., Jutte, E., Veldman, P. H. J. M., Eker, H. H., Koning, G. G., Pierie, J. P. E. N.

    “…Purpose The TransREctus sheath PrePeritoneal procedure (TREPP) was introduced as an alternative open and preperitoneal technique for inguinal hernia mesh…”
    Get full text
    Journal Article
  2. 2

    GSK-3β Function in Bone Regulates Skeletal Development, Whole-Body Metabolism, and Male Life Span by Gillespie, J. R, Bush, J. R, Bell, G. I, Aubrey, L. A, Dupuis, H, Ferron, M, Kream, B, DiMattia, G, Patel, S, Woodgett, J. R, Karsenty, G, Hess, D. A, Beier, F

    Published in Endocrinology (Philadelphia) (01-10-2013)
    “…Glycogen synthase kinase 3 β (GSK-3β) is an essential negative regulator or “brake” on many anabolic-signaling pathways including Wnt and insulin. Global…”
    Get full text
    Journal Article
  3. 3

    Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenase-producing cells promotes islet regeneration by Bell, G. I., Putman, D. M., Hughes-Large, J. M., Hess, D. A.

    Published in Diabetologia (01-06-2012)
    “…Aims/hypothesis We sought to investigate the stimulation of islet regeneration by transplanted human umbilical cord blood (UCB) cells purified according to…”
    Get full text
    Journal Article
  4. 4

    Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway by Quail, D F, Zhang, G, Findlay, S D, Hess, D A, Postovit, L-M

    Published in Oncogene (23-01-2014)
    “…The progression of cancer from localized to invasive disease is requisite for metastasis, and is often characterized by epithelial-to-mesenchymal transition…”
    Get full text
    Journal Article
  5. 5

    MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors by Knorr, K L B, Schneider, P A, Meng, X W, Dai, H, Smith, B D, Hess, A D, Karp, J E, Kaufmann, S H

    Published in Cell death and differentiation (01-12-2015)
    “…MLN4924 (pevonedistat), an inhibitor of the Nedd8 activating enzyme (NAE), has exhibited promising clinical activity in acute myelogenous leukemia (AML). Here…”
    Get full text
    Journal Article
  6. 6

    Thalidomide for the Treatment of Chronic Graft-versus-Host Disease by Vogelsang, Georgia B, Farmer, Evan R, Hess, Allan D, Altamonte, Viki, Beschorner, William E, Jabs, Douglas A, Corio, Russell L, Levin, L. Stefon, Colvin, O. Michael, Wingard, John R, Santos, George W

    Published in The New England journal of medicine (16-04-1992)
    “…CHRONIC graft-versus-host disease (GVHD) is the main late complication of allogeneic bone marrow transplantation, occurring in approximately 40 percent of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Graft-Versus-Host Disease: New Directions for a Persistent Problem by Vogelsang, Georgia B., Hess, Allan D.

    Published in Blood (01-10-1994)
    “…Graft-versus-host disease (GVHD) continues to be a major complication after allogeneic bone marrow transplantation, especially with the increasing use of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Coculture and transplant of purified CD34 Lin and CD34 Lin cells reveals functional interaction between repopulating hematopoietic stem cells by HESS, D. A, KARANU, F. N, LEVAC, K, GALLACHER, L, BHATIA, M

    Published in Leukemia (01-08-2003)
    “…The human hematopoietic stem cell compartment is comprised of repopulating CD34(+) and CD34(-) cells. The interaction between these subsets with respect to…”
    Get full text
    Journal Article
  11. 11

    Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34 cells by MIURA, Y, UEDA, M, TAKAMI, A, SHIOBARA, S, NAKAO, S, HESS, A. D

    Published in Bone marrow transplantation (Basingstoke) (01-10-2003)
    “…Although autologous graft-versus-host disease (GVHD) can be induced by administration of cyclosporin A (CsA) after peripheral blood stem cell transplantation…”
    Get full text
    Journal Article
  12. 12

    Genetic markers associated with progression in early mycosis fungoides by Johnson, V.E., Vonderheid, E.C., Hess, A.D., Eischen, C.M., McGirt, L.Y.

    “…Background Mycosis fungoides (MF) is a rare, but potentially devastating malignancy. It classically presents with cutaneous patches and plaques and can…”
    Get full text
    Journal Article
  13. 13

    Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer by Kennedy, M J, Vogelsang, G B, Jones, R J, Farmer, E R, Hess, A D, Altomonte, V, Huelskamp, A M, Davidson, N E

    Published in Journal of clinical oncology (01-02-1994)
    “…We investigated if interferon gamma (IFN-gamma) could augment cyclosporine (CSA)-induced graft-versus-host disease (GVHD) following autologous bone marrow…”
    Get more information
    Journal Article
  14. 14

    Specificity of effector T lymphocytes in autologous graft-versus-host disease : Role of the major histocompatibility complex class II invariant chain peptide by HESS, A. D, BRIGHT, E. C, THOBURN, C, VOGELSANG, G. B, JONES, R. J, KENNEDY, M. J

    Published in Blood (15-03-1997)
    “…Administration of the immunosuppressive drug cyclosporine after autologous bone marrow transplantation induces a systemic autoimmune syndrome resembling…”
    Get full text
    Journal Article
  15. 15
  16. 16

    C6 Produced by Macrophages Contributes to Cardiac Allograft Rejection by Qian, Zhiping, Wasowska, Barbara A., Behrens, Edward, Cangello, David L., Brody, Jonathan R., Kadkol, ShriHari S., Horwitz, Louis, Liu, Jinhuan, Lowenstein, Charles, Hess, Allan D., Sanfilippo, Fred, Baldwin, William M.

    Published in The American journal of pathology (01-10-1999)
    “…The terminal components of complement C5b-C9 can cause significant injury to cardiac allografts. Using C6-deficient rats, we have found that the rejection of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease : Specificity of cytolytic effector T cells by HESS, A. D, THOBURN, C, HORWITZ, L

    Published in Transplantation (27-03-1998)
    “…Administration of the immunosuppressive drug cyclosporine after syngeneic/autologous bone marrow transplantation paradoxically elicits a systemic autoimmune…”
    Get full text
    Journal Article
  19. 19

    Regulation of OX40 gene expression in graft-versus-host disease by Miura, Y., Thoburn, C.J., Bright, E.C., Arai, S., Hess, A.D.

    Published in Transplantation proceedings (2005)
    “…OX40 (CD134), a member of the tumor necrosis factor receptor superfamily, is expressed on activated T cells, including CD4 +CD25 + T regulatory (Treg) cells…”
    Get full text
    Journal Article
  20. 20

    Ambulatory sentinel node biopsy under local anaesthesia for patients with early breast cancer by van Berlo, C.L.H, Hess, D.A, Nijhuis, P.A.H, Leys, E, Gerritsen, H.A.M, Schapers, R.F.M

    Published in European journal of surgical oncology (01-05-2003)
    “…Aims: Sentinel lymph node biopsy (SLNB) may permit reliable identification of patients with axillary node involvement. The aim of this study was to report our…”
    Get full text
    Journal Article